Diabetes MCQ PDF

\#\#\# Page 31: Emerging Therapies 1\. \*\*Which class of medications has shown promise in the treatment of diabetes by mimicking incretin hormones?\*\* \- A) Sulfonylureas \- B) GLP-1 receptor agonists \- C) Thiazolidinediones \- D) Biguanides \*\*Answer:\*\* B) GLP-1 receptor agonists 2\. \...

\#\#\# Page 31: Emerging Therapies 1\. \*\*Which class of medications has shown promise in the treatment of diabetes by mimicking incretin hormones?\*\* \- A) Sulfonylureas \- B) GLP-1 receptor agonists \- C) Thiazolidinediones \- D) Biguanides \*\*Answer:\*\* B) GLP-1 receptor agonists 2\. \*\*What is a key benefit of using SGLT2 inhibitors in diabetes management?\*\* \- A) Weight gain \- B) Increased insulin secretion \- C) Reduction of cardiovascular risk \- D) Decreased urinary glucose excretion \*\*Answer:\*\* C) Reduction of cardiovascular risk \#\#\# Page 32: Continuous Glucose Monitoring (CGM) 1\. \*\*What is the primary advantage of continuous glucose monitoring for diabetic patients?\*\* \- A) It eliminates the need for insulin. \- B) It provides real-time glucose readings. \- C) It is less accurate than fingerstick testing. \- D) It requires frequent hospital visits. \*\*Answer:\*\* B) It provides real-time glucose readings. 2\. \*\*Which population may benefit the most from CGM technology?\*\* \- A) Individuals with Type 1 Diabetes \- B) Individuals without diabetes \- C) Only elderly patients \- D) Individuals with hypertension \*\*Answer:\*\* A) Individuals with Type 1 Diabetes \#\#\# Page 33: Telehealth in Diabetes Care 1\. \*\*How has telehealth impacted diabetes management?\*\* \- A) Decreased access to care \- B) Increased patient engagement and convenience \- C) Eliminated the need for healthcare providers \- D) Reduced communication between patients and providers \*\*Answer:\*\* B) Increased patient engagement and convenience 2\. \*\*Which of the following is a potential limitation of telehealth for diabetes care?\*\* \- A) Improved medication adherence \- B) Limited access to technology \- C) Enhanced patient education \- D) Greater flexibility in scheduling \*\*Answer:\*\* B) Limited access to technology \#\#\# Page 34: Patient-Centered Care 1\. \*\*What is a core principle of patient-centered care in diabetes management?\*\* \- A) Provider-driven decision-making \- B) Individualized treatment plans \- C) Standardized protocols for all patients \- D) Focus on medication adherence only \*\*Answer:\*\* B) Individualized treatment plans 2\. \*\*Why is it important to involve patients in their diabetes care decisions?\*\* \- A) It reduces the need for education. \- B) It increases patient satisfaction and adherence. \- C) It complicates the treatment process. \- D) It has no impact on outcomes. \*\*Answer:\*\* B) It increases patient satisfaction and adherence. \#\#\# Page 35: Cultural Competence in Diabetes Care 1\. \*\*What is cultural competence in healthcare?\*\* \- A) Understanding only the patient\'s language \- B) Awareness of and respect for diverse cultural backgrounds \- C) Providing the same treatment to all patients \- D) Focusing solely on clinical guidelines \*\*Answer:\*\* B) Awareness of and respect for diverse cultural backgrounds 2\. \*\*Why is cultural competence important in diabetes management?\*\* \- A) It limits the treatment options available. \- B) It enhances communication and trust between patients and providers. \- C) It has no influence on patient outcomes. \- D) It simplifies the care process. \*\*Answer:\*\* B) It enhances communication and trust between patients and providers. \#\#\# Page 36: Health Disparities in Diabetes 1\. \*\*Which of the following factors can contribute to health disparities in diabetes care?\*\* \- A) Socioeconomic status \- B) Access to education \- C) Geographic location \- D) All of the above \*\*Answer:\*\* D) All of the above 2\. \*\*What is a common barrier to effective diabetes management in underserved populations?\*\* \- A) High health literacy \- B) Availability of healthcare resources \- C) Cultural beliefs and practices \- D) Non-compliance with dietary recommendations \*\*Answer:\*\* C) Cultural beliefs and practices \#\#\# Page 37: Diabetes Prevention Programs 1\. \*\*What is the primary goal of diabetes prevention programs?\*\* \- A) To cure diabetes \- B) To reduce the incidence of Type 2 Diabetes \- C) To increase medication use \- D) To promote weight gain \*\*Answer:\*\* B) To reduce the incidence of Type 2 Diabetes 2\. \*\*Which strategy is commonly used in diabetes prevention programs?\*\* \- A) High-calorie diet \- B) Increased physical inactivity \- C) Lifestyle modification through diet and exercise \- D) Sole reliance on medication \*\*Answer:\*\* C) Lifestyle modification through diet and exercise \#\#\# Page 38: Community Engagement 1\. \*\*Why is community engagement important in diabetes management?\*\* \- A) It isolates patients from healthcare providers. \- B) It fosters support networks and resources. \- C) It reduces patient autonomy. \- D) It complicates healthcare access. \*\*Answer:\*\* B) It fosters support networks and resources. 2\. \*\*Which of the following is a method to enhance community engagement in diabetes care?\*\* \- A) Limited outreach programs \- B) Health fairs and educational workshops \- C) Restricting access to information \- D) Individualized care only \*\*Answer:\*\* B) Health fairs and educational workshops \#\#\# Page 39: Policy and Advocacy 1\. \*\*What role does policy play in diabetes management?\*\* \- A) It has no effect on patient care. \- B) It can influence healthcare access and funding for diabetes programs. \- C) It complicates the healthcare system. \- D) It focuses only on medication regulation. \*\*Answer:\*\* B) It can influence healthcare access and funding for diabetes programs. 2\. \*\*Which of the following is a key advocacy issue in diabetes care?\*\* \- A) Reducing access to healthcare \- B) Promoting health equity and access to treatment \- C) Limiting educational resources \- D) Increasing costs of diabetes medications \*\*Answer:\*\* B) Promoting health equity and access to treatment \#\#\# Page 40: Future Directions in Diabetes Research 1\. \*\*What is a current focus in diabetes research?\*\* \- A) Developing new insulin formulations \- B) Understanding the genetic basis of diabetes \- C) Enhancing patient education methods \- D) All of the above \*\*Answer:\*\* D) All of the above 2\. \*\*Which area of research is expected to improve diabetes management in the future?\*\* \- A) High-fat diets \- B) Personalized medicine and genomics \- C) Increased reliance on oral medications only \- D) Limiting technology in care \*\*Answer:\*\* B) Personalized medicine and genomics